Search results
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 1 week agoAstraZeneca’s AZN first-quarter 2024 core earnings of $1.03 per American depositary share (ADS) beat...
Will AstraZeneca (AZN) Deliver a Beat This Earnings Season?
Zacks via Yahoo Finance· 2 years agoStrong demand trends for AstraZeneca's (AZN) key drugs, Lynparza, Tagrisso, Imfinzi and Farxiga are...
AstraZeneca (AZN) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoHigher sales of AstraZeneca's (AZN) key medicines, Lynparza, Tagrisso and Imfinzi and Farxiga are...
‘A huge shock to the system’: Doctors warn about asthma inhaler switch coming in January
CNN via Yahoo News· 4 months agoStarting January 1, a drug that thousands of patients depend on to help them breathe will disappear...
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 week agoImage source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q1 2024 Earnings Call Apr 25, 2024,...
What Do Corticosteroids Do and When Do You Need Them?
Health via Yahoo News· 7 months agoCorticosteroids are important, sometimes life-saving therapies and the most widely prescribed drugs...
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
Zacks via Yahoo Finance· 6 months agoAstraZeneca’s AZN third-quarter 2023 core earnings of 87 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN fourth-quarter 2022 core earnings of 69 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS)...
AstraZeneca's COVID-19 Vaccine Loses Shine, Cancer Drug Imfinzi & Emerging Markets Stabilize Q1...
Benzinga via Yahoo Finance· 1 year agoAstraZeneca Plc (NASDAQ: AZN) has reported Q1 FY23 core EPS of $1.92, up 1% Y/Y (+6% on constant...